Leading US and European Medical Public-Private Partnerships Announce Agreement

The Predictive Safety Testing Consortium (PSTC) led by the Critical Path Institute (C-Path) and the Safer and Faster Evidence-based Translation (SAFE-T) consortium sponsored by the Innovative Medicines Initiative (IMI), announced today the signature of an agreement to work together in their efforts to improve drug safety.

Advancing Adoption of Novel Safety Biomarkers into Drug Development through Voluntary Submission of Data at US FDA, EMA, and PMDA

Presenter – E Gribble Walker, M Brumfield, E H Dennis

Conference – Society of Toxicologists 2013 Annual Meeting